Two recent in vitro studies delineate the potential of SPARC as a suppressor of tumorigenic potential in human melanoma and breast cancer cells via the addition of either antisense RNA or the transfection of SPARC (Ledda et al, 1997; Dhanesuan et al, 2002). The gene discussed is SPARC; the disease is breast cancer.